Lovelace Biomedical Research Institute

UEI MBT9RXJJ7428 · NM · SAM.gov record ↗

$11.7M

FY2025 obligations

Contract awards

Dec 18, 2018

First action

Jun 15, 2026

Latest action

Obligations by agency

Department Of Health And Human Services$11.6M
Department Of Defense$42K

Obligations by NAICS

Monthly obligations

Oct 24

Nov 24

Dec 24

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Nov 25

Dec 25

Feb 26

Mar 26

Apr 26

Jun 26

Contracts ending within 18 months (recompete watch)

75A50123F61001 ↗$2.0M
RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])
Ends
Sep 17, 2026
Started
Sep 28, 2023
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714
75F40122F19001 ↗$0
INCREASE CLINICAL STUDY TIME
Ends
Feb 21, 2027
Started
Sep 21, 2022
Agency
Food And Drug Administration
NAICS
541690
75F40123F19002 ↗$0
TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR
Ends
Sep 28, 2027
Started
Sep 28, 2023
Agency
Food And Drug Administration
NAICS
541690
75F40125P00216 ↗$7.1M
SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).
Ends
Sep 28, 2027
Started
Sep 18, 2025
Agency
Food And Drug Administration
NAICS
541380

PIID	Description	Agency	NAICS	Obligated	Start	End
75A50123F61001 ↗	RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])	Office Of Assistant Secretary For Preparedness And Response	541714	$2.0M	Sep 28, 2023	Sep 17, 2026
75F40122F19001 ↗	INCREASE CLINICAL STUDY TIME	Food And Drug Administration	541690	$0	Sep 21, 2022	Feb 21, 2027
75F40123F19002 ↗	TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR	Food And Drug Administration	541690	$0	Sep 28, 2023	Sep 28, 2027
75F40125P00216 ↗	SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).	Food And Drug Administration	541380	$7.1M	Sep 18, 2025	Sep 28, 2027

Largest awards

75F40125P00216 ↗$7.1M
SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).
Ends
Sep 28, 2027
Started
Sep 18, 2025
Agency
Food And Drug Administration
NAICS
541380
75F40119C10161 ↗$2.5M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
Ends
Jun 29, 2025
Started
Sep 25, 2019
Agency
Food And Drug Administration
NAICS
541380
75A50123F61001 ↗$2.0M
RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])
Ends
Sep 17, 2026
Started
Sep 28, 2023
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714
75N95020F00001 ↗$1.7M
NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)
Ends
May 23, 2026
Started
Sep 24, 2020
Agency
National Institutes Of Health
NAICS
541712
75N93022F00001 ↗$194K
TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA
Ends
Apr 14, 2026
Started
Nov 14, 2021
Agency
National Institutes Of Health
NAICS
541715
W81XWH22P0157 ↗$42K
ANNUAL SOFTWARE LICENSE/MAINTENANCE AGREEMENT FOR THE ANIMAL MANAGEMENT SYSTEM.
Ends
Sep 18, 2025
Started
Sep 15, 2022
Agency
Defense Health Agency
NAICS
511210
75A50123F61001 ↗$21K
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
Ends
Jul 18, 2026
Started
Jul 19, 2023
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714
75N93025D00021 ↗$10K
EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.
Ends
—
Started
Sep 29, 2025
Agency
National Institutes Of Health
NAICS
541715
HT001122D0030 ↗$0
OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT.
Ends
—
Started
Jun 19, 2022
Agency
Defense Health Agency
NAICS
541714
75N95024F00001 ↗$0
EVALUATION OF POTENTIAL RESPIRATORY STIMULANT. TO4. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MAY 30, 2025.
Ends
May 29, 2025
Started
Mar 20, 2024
Agency
National Institutes Of Health
NAICS
541715
75N95020F00002 ↗$0
CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN.
Ends
Jun 29, 2025
Started
Sep 17, 2020
Agency
National Institutes Of Health
NAICS
541715
75N95022F00001 ↗$0
BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS
Ends
Jun 29, 2025
Started
Jun 16, 2022
Agency
National Institutes Of Health
NAICS
541715
75N95020F00005 ↗$0
EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.
Ends
Jul 14, 2025
Started
Sep 24, 2020
Agency
National Institutes Of Health
NAICS
541715
75N95020F00003 ↗$0
NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS.
Ends
Jul 30, 2025
Started
Sep 27, 2020
Agency
National Institutes Of Health
NAICS
541715
75N95021F00001 ↗$0
CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN
Ends
Mar 30, 2026
Started
Sep 23, 2021
Agency
National Institutes Of Health
NAICS
541715
75F40122F19001 ↗$0
INCREASE CLINICAL STUDY TIME
Ends
Feb 21, 2027
Started
Sep 21, 2022
Agency
Food And Drug Administration
NAICS
541690
75F40123F19002 ↗$0
TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR
Ends
Sep 28, 2027
Started
Sep 28, 2023
Agency
Food And Drug Administration
NAICS
541690
75A50122D00008 ↗$0
LOVELACE BIOMEDICAL RESEARCH INSTITUTE(CHEM) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT
Ends
—
Started
Jul 27, 2022
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714
75A50122D00013 ↗$0
LOVELACE BIOMEDICAL RESEARCH INSTITUTE (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT
Ends
—
Started
Sep 8, 2022
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714
75F40123D00039 ↗$0
AWARD OF FIVE-YEAR IDIQ FOR CTP- ASSESSING TOBACCO-RELATED CLINICAL OUTCOMES AND HUMAN BEHAVIORS IN TOBACCO
Ends
—
Started
Sep 25, 2023
Agency
Food And Drug Administration
NAICS
541690
75N93021D00031 ↗$0
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS
Ends
—
Started
Aug 31, 2021
Agency
National Institutes Of Health
NAICS
541714
75N93022D00009 ↗$0
THE CONTRACTOR SHALL PROVIDE PRECLINICAL DEVELOPMENT SUPPORT FOR CANDIDATE PRODUCTS AND DRUG DEVELOPMENT ACTIVITIES.
Ends
—
Started
Nov 14, 2021
Agency
National Institutes Of Health
NAICS
541715
75N95019D00030 ↗$0
EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION.
Ends
—
Started
Sep 25, 2019
Agency
National Institutes Of Health
NAICS
541715
75F40123F19001 ↗$0
TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHING TO ENDS
Ends
Mar 28, 2026
Started
Sep 26, 2023
Agency
Food And Drug Administration
NAICS
541690
75N95024F00002 ↗$0
RESPIRATORY INTERACTION STUDIES IN RODENTS, ABILITY OF A TEST ARTICLE TO REVERSE THE RESPIRATORY DEPRESSANT EFFECTS OF OPIOIDS. TO5.POP: MARCH 21, 2024 - MARCH 31, 2026.
Ends
Mar 30, 2026
Started
Mar 20, 2024
Agency
National Institutes Of Health
NAICS
541715

PIID	Description	Agency	NAICS	Obligated	Start	End
75F40125P00216 ↗	SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).	Food And Drug Administration	541380	$7.1M	Sep 18, 2025	Sep 28, 2027
75F40119C10161 ↗	STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.	Food And Drug Administration	541380	$2.5M	Sep 25, 2019	Jun 29, 2025
75A50123F61001 ↗	RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])	Office Of Assistant Secretary For Preparedness And Response	541714	$2.0M	Sep 28, 2023	Sep 17, 2026
75N95020F00001 ↗	NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)	National Institutes Of Health	541712	$1.7M	Sep 24, 2020	May 23, 2026
75N93022F00001 ↗	TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA	National Institutes Of Health	541715	$194K	Nov 14, 2021	Apr 14, 2026
W81XWH22P0157 ↗	ANNUAL SOFTWARE LICENSE/MAINTENANCE AGREEMENT FOR THE ANIMAL MANAGEMENT SYSTEM.	Defense Health Agency	511210	$42K	Sep 15, 2022	Sep 18, 2025
75A50123F61001 ↗	BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES	Office Of Assistant Secretary For Preparedness And Response	541714	$21K	Jul 19, 2023	Jul 18, 2026
75N93025D00021 ↗	EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.	National Institutes Of Health	541715	$10K	Sep 29, 2025	—
HT001122D0030 ↗	OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT.	Defense Health Agency	541714	$0	Jun 19, 2022	—
75N95024F00001 ↗	EVALUATION OF POTENTIAL RESPIRATORY STIMULANT. TO4. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MAY 30, 2025.	National Institutes Of Health	541715	$0	Mar 20, 2024	May 29, 2025
75N95020F00002 ↗	CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN.	National Institutes Of Health	541715	$0	Sep 17, 2020	Jun 29, 2025
75N95022F00001 ↗	BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS	National Institutes Of Health	541715	$0	Jun 16, 2022	Jun 29, 2025
75N95020F00005 ↗	EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.	National Institutes Of Health	541715	$0	Sep 24, 2020	Jul 14, 2025
75N95020F00003 ↗	NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS.	National Institutes Of Health	541715	$0	Sep 27, 2020	Jul 30, 2025
75N95021F00001 ↗	CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN	National Institutes Of Health	541715	$0	Sep 23, 2021	Mar 30, 2026
75F40122F19001 ↗	INCREASE CLINICAL STUDY TIME	Food And Drug Administration	541690	$0	Sep 21, 2022	Feb 21, 2027
75F40123F19002 ↗	TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR	Food And Drug Administration	541690	$0	Sep 28, 2023	Sep 28, 2027
75A50122D00008 ↗	LOVELACE BIOMEDICAL RESEARCH INSTITUTE(CHEM) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT	Office Of Assistant Secretary For Preparedness And Response	541714	$0	Jul 27, 2022	—
75A50122D00013 ↗	LOVELACE BIOMEDICAL RESEARCH INSTITUTE (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT	Office Of Assistant Secretary For Preparedness And Response	541714	$0	Sep 8, 2022	—
75F40123D00039 ↗	AWARD OF FIVE-YEAR IDIQ FOR CTP- ASSESSING TOBACCO-RELATED CLINICAL OUTCOMES AND HUMAN BEHAVIORS IN TOBACCO	Food And Drug Administration	541690	$0	Sep 25, 2023	—
75N93021D00031 ↗	COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS	National Institutes Of Health	541714	$0	Aug 31, 2021	—
75N93022D00009 ↗	THE CONTRACTOR SHALL PROVIDE PRECLINICAL DEVELOPMENT SUPPORT FOR CANDIDATE PRODUCTS AND DRUG DEVELOPMENT ACTIVITIES.	National Institutes Of Health	541715	$0	Nov 14, 2021	—
75N95019D00030 ↗	EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION.	National Institutes Of Health	541715	$0	Sep 25, 2019	—
75F40123F19001 ↗	TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHING TO ENDS	Food And Drug Administration	541690	$0	Sep 26, 2023	Mar 28, 2026
75N95024F00002 ↗	RESPIRATORY INTERACTION STUDIES IN RODENTS, ABILITY OF A TEST ARTICLE TO REVERSE THE RESPIRATORY DEPRESSANT EFFECTS OF OPIOIDS. TO5.POP: MARCH 21, 2024 - MARCH 31, 2026.	National Institutes Of Health	541715	$0	Mar 20, 2024	Mar 30, 2026

Subsidiaries under this parent

Lovelace Biomedical And Environmental Research Institute, INC. ($-164K)